about
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes.Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non-Small Cell Lung Carcinoma.Cell genomics and immunosuppressive biomarker expression influence PD-L1 immunotherapy treatment responses in HNSCC-a computational study.Fully Automated RNAscope In Situ Hybridization Assays for Formalin-Fixed Paraffin-Embedded Cells and Tissues.Aligning Digital CD8(+) Scoring and Targeted Next-Generation Sequencing with PD-L1 Expression: A Pragmatic Approach in Early-Stage Squamous Cell Lung Carcinoma.PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung CancerIntratumoral heterogeneity of programmed cell death ligand-1 expression is common in lung cancer.Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization.RNAscope in situ hybridization confirms mRNA integrity in formalin-fixed, paraffin-embedded cancer tissue samples.PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability.Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: implications for assessment by small biopsy.Programmed death-ligand 1 expression according to epidermal growth factor receptor mutation status in pretreated non-small cell lung cancer.Update on Immunohistochemistry for the Diagnosis of Lung Cancer.PD-L1 expression testing in non-small cell lung cancer.Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.A comparative study of PD-L1 immunohistochemical assays with four reliable antibodies in thymic carcinoma.Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers
P2860
Q37277198-833DC5CD-79B6-4DCD-BB7D-B72D3014BCF1Q38673895-B5498B81-42FB-469E-99C7-C9B71E9CD772Q38696133-4C8B41CE-4552-4B42-82DA-D124AF3CF672Q39757066-79FD02C8-DA3E-4ACB-B17E-6BFC68D1B037Q40496586-188B93F0-0287-4534-B0BE-B883AD5EB915Q41770303-AEFD7A56-4C56-47CD-999C-A2EC675537E6Q46037895-2EF56C53-08BC-468F-A0D1-464489D49470Q46178018-EFF9C214-24E1-407C-B9DF-501183084F33Q47102080-0D46F593-148B-4A54-93D1-C39F4A94C1DCQ47115697-0E3D56C6-EE73-4645-8D9A-0EB324A80393Q48088758-31862B5E-6C79-4B58-8094-9F0D7786E891Q49163406-1C132F42-085D-4A72-B85A-1E7183EA83FAQ51733982-0B285643-4FCE-4293-92FB-F775219CA105Q52584388-D04DFBE1-16E3-4D94-A132-41FDAD4EC1D6Q52682751-4B45568C-AC09-42E2-812C-B114BBA93925Q55229901-B983BE0D-A1E7-460F-89D6-774C1191A446Q55318335-DE66A9F6-F28B-4972-9C25-17166F263AFDQ56892179-06E7B820-EC45-45ED-B17D-E35DBB4124FF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PD-L1 Expression in Lung Cancer.
@en
PD-L1 Expression in Lung Cancer.
@nl
type
label
PD-L1 Expression in Lung Cancer.
@en
PD-L1 Expression in Lung Cancer.
@nl
prefLabel
PD-L1 Expression in Lung Cancer.
@en
PD-L1 Expression in Lung Cancer.
@nl
P2093
P2860
P1476
PD-L1 Expression in Lung Cancer.
@en
P2093
Caicun Zhou
David L Rimm
Fred R Hirsch
Theresa A Boyle
P2860
P304
P356
10.1016/J.JTHO.2016.04.014
P577
2016-04-23T00:00:00Z